Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susie H Park

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Psychiatry Investigation|January 5, 2012
Completion of chronic hepatitis C virus treatment in interferon-induced major depressive disorder with psychotic featuresSusie H Park
Current Drug Safety|August 7, 2013
Liver injury associated with antidepressantsSusie H Park, Risa Ishino
CNS Drugs|December 25, 2014
Seizure associated with clozapine: incidence, etiology, and managementAndrew M Williams, Susie H Park
Clinical Therapeutics|October 11, 2011
Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virusRobin C Wackernah, Mimi Lou, Susie H Park
CNS Drugs|March 15, 2017
A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with AntipsychoticsYawen Jiang, Jeffrey S McCombs, Susie H Park
The Annals of Pharmacotherapy|March 2, 2006
Telbivudine: a novel nucleoside analog for chronic hepatitis BJiwon W Kim, Susie H Park, Stan G Louie
Journal of Pharmacy Practice|October 25, 2013
Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?Susie H Park, Robin C Wackernah, Glen L Stimmel
Infection|August 31, 2020
Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitisS Alexander Winans, Richelle L Guerrero-Wooley, Susie H Park, et al.
The Mental Health Clinician|November 23, 2020
Impact of pharmacists on outcomes for patients with psychiatric or neurologic disordersAmy Werremeyer, Jolene Bostwick, Carla Cobb, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Psychiatry Investigation|January 5, 2012
Completion of chronic hepatitis C virus treatment in interferon-induced major depressive disorder with psychotic featuresSusie H Park
Current Drug Safety|August 7, 2013
Liver injury associated with antidepressantsSusie H Park, Risa Ishino
CNS Drugs|December 25, 2014
Seizure associated with clozapine: incidence, etiology, and managementAndrew M Williams, Susie H Park
Clinical Therapeutics|October 11, 2011
Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virusRobin C Wackernah, Mimi Lou, Susie H Park
CNS Drugs|March 15, 2017
A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with AntipsychoticsYawen Jiang, Jeffrey S McCombs, Susie H Park
The Annals of Pharmacotherapy|March 2, 2006
Telbivudine: a novel nucleoside analog for chronic hepatitis BJiwon W Kim, Susie H Park, Stan G Louie
Journal of Pharmacy Practice|October 25, 2013
Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?Susie H Park, Robin C Wackernah, Glen L Stimmel
Infection|August 31, 2020
Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitisS Alexander Winans, Richelle L Guerrero-Wooley, Susie H Park, et al.
The Mental Health Clinician|November 23, 2020
Impact of pharmacists on outcomes for patients with psychiatric or neurologic disordersAmy Werremeyer, Jolene Bostwick, Carla Cobb, et al.
Pageof 1